Rolf Mahlberg | Charles Explorer

Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer

2017 | Publication without faculty affiliation